Primary Myelofibrosis — Trials

Primary Myelofibrosis — Trials · CancerIndex

Clinical trials

Registered studies

242 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 66
Recruiting: 36
Ph III recruiting: 2
Growth YoY: —
Industry share: 30%
Top sponsor: City of Hope Medical Center
Termination share: 38.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (46)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07215832	Karyopharm Expanded Access Program for Selinexor(KEAP)	available	—	—	Karyopharm Therapeutics IncINDUSTRY	0	Mar 2, 2026	clinicaltrials
NCT04745637	Managed Access Programs for INC424, Ruxolitinib	available	—	—	Novartis PharmaceuticalsINDUSTRY	0	Nov 18, 2025	clinicaltrials